Bone is a vital organ in the body, and its cells undergo continuous transformation throughout our life. Bone research and drug development heavily reply of use of medical imaging throughout the development process.
The integration of innovative drug developments and advancements in medical imaging is introducing significant improvements in the management of bone health, providing refined and effective solutions for conditions like osteoporosis.
Medical imaging has evolved beyond being merely a diagnostic tool; it’s a critical component in developing bone therapeutics, facilitating the evaluation and refinement of new drugs and treatments. Medical imaging is vital for progress in medical interventions for bone disorders, aiming for more innovative, accurate, and patient-centric approaches, with the potential to significantly enhance the quality of life for patients.
Variety of therapies is already on a market, but there is plenty of demand for newer safer and more effective medicines, as well as bio-similar versions of well-known blockbusters.
We discuss here various #imaging techniques and their impact in taking #compounds through #regulatory approvals.
Read more: https://www.linkedin.com/pulse/new-drugs-vs-tools-bone-health-image-analysis-ltd
#AI #MedicalImaging #DrugDiscovery #PrecisionMedicine #ClinicalTrials #DrugRepurposing #Biotechnology #Healthcare #Innovation #Pharmaceuticals #PersonalizedMedicine #MedicalImageAnalysis #MRI #CT #Ultrasound #PET #PharmaceuticalInnovationv#Biotech #CEOv #AI-Powered #DrugDiscovery #Biotech #LifeSciences #Technology #osteoarthritis #MachineLearning #LifeSciences #BiotechInnovation #MedicalTech #FutureOfPharma #BoneHealth #DXA #CT #ASBMR
Reach out to our expert team, as you are designing and planning your trial. imaging.experts@ia-grp.com
About IAG, Image Analysis Group
IAG, Image Analysis Group is a strategic partner to bio-pharmaceutical companies developing new treatments to improve patients’ lives. Our dynamic Strategy, Trial Solutions and Bio-Partnering divisions work closely to meet critical needs of biotechnology companies: funding, clinical development, and monetization of their assets. We fuse decades of therapeutic insights, risk-sharing business model and agile culture to accelerate novel drug development. IAG broadly leverages its core imaging expertise, proprietary technology platform DYNAMIKA and capabilities to support an objective early go no/ go decision and drive excellence for tomorrow’s innovative therapeutic agents with speed.